Pancreatic enzyme replacement therapy (PERT) is often an essential component of the treatment regimen for patients with pancreatic cancer, but it can be very pricey.
“Out-of-pocket costs for a 30-day supply of enzymes for Medicare beneficiaries can be as high as $1000,” commented Arjun Gupta, MD, an oncology fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Read more . . .